Related Experiment Video

Updated: Jul 21, 2025

Author Spotlight: Assessing the Impact of Novel Iron Chelators on Cancer Cell Metabolism
05:36

Author Spotlight: Assessing the Impact of Novel Iron Chelators on Cancer Cell Metabolism

Published on: February 23, 2024

511

Novel Iron Chelator SK4 Drives Cytotoxicity through Inhibiting Mitochondrial Metabolism in Ovarian and Triple

Gina Abdelaal1, Andrew Carter1, William Cheung1

  • 1Department of Applied Sciences, Faculty of Health and Life Sciences, Northumbria University, Newcastle upon Tyne NE1 8ST, UK.

Biomedicines
|July 29, 2023
PubMed

Insights

Iron chelator SK4 targets cancer by inhibiting energy metabolism and potentially inducing ceramide. This dual action, entering cells via LAT1 transporter, offers a novel anti-cancer therapy approach.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Iron chelation is a promising anti-cancer strategy targeting DNA replication, mitochondrial metabolism, and oncogenic pathways.
  • Iron chelator SK4 uniquely targets both iron addiction and LAT1 overexpression, a common tumor-associated amino acid transporter.

Purpose of the Study:

  • To elucidate the mechanism of action of iron chelator SK4.
  • To investigate SK4's effects on cellular metabolism and apoptosis in ovarian (SKOV3) and triple-negative breast cancer (MDA MB 231) cell lines.

Main Methods:

  • Proteomics, metabolomics, and lipidomics were employed to analyze cellular changes.
  • Seahorse real-time analysis assessed mitochondrial respiration.
  • Cellular responses were studied in SKOV3 and MDA MB 231 cell lines.

Main Results:

  • Proteomics revealed significant enrichment of metabolism-related pathways post-SK4 treatment.
  • Seahorse analysis confirmed SK4's impact on mitochondrial respiration.
  • Metabolomics indicated increased AMP and glucose-1-phosphate levels.
  • Lipidomics showed decreased phospholipid synthesis in SKOV3 cells, contrasting with prior ceramide-related findings.

Conclusions:

  • Impaired energy metabolism is a key mechanism underlying SK4-induced apoptosis.
  • Ceramide induction may play a role in SK4's phenotypic outcomes.
  • SK4 demonstrates potential as an anti-cancer agent by disrupting fundamental cellular processes.
Keywords:
SK4cancerironiron chelatormitochondriatherapy

More Related Videos

Enrichment for Chemoresistant Ovarian Cancer Stem Cells from Human Cell Lines11:50

Enrichment for Chemoresistant Ovarian Cancer Stem Cells from Human Cell Lines

Published on: September 10, 2014

13.5K
Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen19:44

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen

Published on: May 30, 2012

18.7K

Related Concept Videos

Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
14.5K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.7K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
The Electron Transport Chain01:30

The Electron Transport Chain

The electron transport chain or oxidative phosphorylation is an exothermic process in which free energy released during electron transfer reactions is coupled to ATP synthesis. This process is a significant source of energy in aerobic cells, and therefore inhibitors of the electron transport chain can be detrimental to the cell's metabolic processes.
Inhibitors of the electron transport chain
Rotenone, a widely used pesticide, prevents electron transfer from Fe-S cluster to ubiquinone or Q...
16.9K